View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Endocrinology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 23, 2024
2 min read
Save

Children, adults more likely to develop type 1 diabetes if father has disease vs. mother

Children, adults more likely to develop type 1 diabetes if father has disease vs. mother

Both children and adults are more likely to be diagnosed with type 1 diabetes if they have a father with type 1 diabetes vs. a mother with the condition, according to a speaker.

SPONSORED CONTENT
September 23, 2024
2 min read
Save

Dollar cost averaging and lump sum investing: Take the emotion out of investing

Dollar cost averaging and lump sum investing: Take the emotion out of investing

Time in the market is far more important than timing the market. Long-term investors will utilize both the strategies of dollar cost averaging and lump sum investing to reach their investment goals.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
September 21, 2024
3 min read
Save

Annual CMHC: Honoring the life and legacy of CMHC co-chair George L. Bakris, MD

Annual CMHC: Honoring the life and legacy of CMHC co-chair George L. Bakris, MD

For nearly 2 decades, George L. Bakris, MD, was a pillar of the Cardiometabolic Health Congress, sharing his expertise, passion and unwavering dedication to advancing cardiometabolic health.

SPONSORED CONTENT
September 20, 2024
4 min read
Save

FTC files administrative complaint vs. PBMs alleging artificially inflated insulin prices

FTC files administrative complaint vs. PBMs alleging artificially inflated insulin prices

The Federal Trade Commission announced it has filed an administrative complaint against three pharmacy benefit managers alleging “anticompetitive and unfair” rebate practices that have artificially inflated the price of insulin drugs.

SPONSORED CONTENT
September 20, 2024
1 min read
Save

Novel oral drug linked to weight loss in people with obesity, metabolic syndrome

Novel oral drug linked to weight loss in people with obesity, metabolic syndrome

Novo Nordisk announced that monlunabant, a novel small molecule oral cannabinoid receptor 1 inverse agonist, was associated with weight loss in a phase 2a study of people with obesity and metabolic syndrome.

SPONSORED CONTENT
September 20, 2024
3 min read
Save

Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes

Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes

In a small study of patients with type 1 diabetes using an automated insulin delivery system, semaglutide improved glucose control vs. placebo, researchers reported at the European Association for the Study of Diabetes Annual Meeting.

SPONSORED CONTENT
September 19, 2024
3 min read
Save

Higher BMI in women, men tied to longer time to pregnancy, increased miscarriage odds

Higher BMI in women, men tied to longer time to pregnancy, increased miscarriage odds

BMI in the overweight or obese range for both women and men during preconception or early pregnancy was linked to time to pregnancy success and miscarriage risk, according to study results published in JAMA Network Open.

SPONSORED CONTENT
September 19, 2024
6 min read
Save

Stress, infertility ‘interwoven’ in PCOS, but treatments may improve odds for pregnancy

Stress, infertility ‘interwoven’ in PCOS, but treatments may improve odds for pregnancy

Women with polycystic ovary syndrome have a higher likelihood of experiencing infertility and subfertility, which can harm mental health and trigger stress, but not everyone with this disorder will require assisted reproduction to conceive.

SPONSORED CONTENT
September 19, 2024
3 min read
Save

Off-label semaglutide, tirzepatide lower HbA1c and body weight in type 1 diabetes

Off-label semaglutide, tirzepatide lower HbA1c and body weight in type 1 diabetes

Adults with type 1 diabetes using either semaglutide or tirzepatide off-label had greater decreases in body weight and HbA1c than those not treated with either medication, according to a speaker.

SPONSORED CONTENT
September 19, 2024
2 min read
Save

Obesity linked to higher risk for Barrett’s esophagus progression to dysplasia, cancer

Obesity linked to higher risk for Barrett’s esophagus progression to dysplasia, cancer

Among patients with Barrett’s esophagus, every 5 kg/m2 increase in BMI was associated with up to a 6% relative increase in the risk for malignant progression, according to a systematic review and meta-analysis.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails